6
Views
2
CrossRef citations to date
0
Altmetric
Original

Sequence variation in the CC-chemokine ligand 2 promoter of pigtailed macaques is not associated with the incidence or severity of neuropathology in a simian immunodeficiency virus model of human immunodeficiency virus central nervous system disease

, &
Pages 411-419 | Received 05 Jul 2006, Accepted 07 Sep 2006, Published online: 10 Jul 2009

References

  • Aguilar F, Gonzalez-Escribano M F, Sanchez-Roman J, Nunez-Roldan A. MCP-1 promoterpolymorphism in Spanish patients with systemic lupus erythematosus. Tissue Antigens 2001; 58: 335–338, [INFOTRIEVE], [CSA]
  • Bernasconi S, Cinque P, Peri G, Sozzani S, Crociati A, Torri W, Vicenzi E, Vago L, Lazzarin A, Poli G, Mantovani A. Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis. J Infect Dis 1996; 174: 1098–1101, [INFOTRIEVE], [CSA]
  • Cinque P, Vago L, Mengozzi M, Torri V, Ceresa D, Vicenzi E, Transidico P, Vagani A, Sozzani S, Mantovani A, Lazzarin A, Poli G. Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS 1998; 12: 1327–1332, [INFOTRIEVE], [CSA]
  • Conant K, Garzino-Demo A, Nath A, McArthur J C, Halliday W, Power C, Gallo R C, Major E O. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci U S A 1998; 95: 3117–3121, [INFOTRIEVE], [CROSSREF], [CSA]
  • Dore G J, Correll P K, Li Y, Kaldor J M, Cooper D A, Brew B J. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 1999; 13: 1249–1253, [INFOTRIEVE], [CROSSREF], [CSA]
  • Eugenin E A, Osiecki K, Lopez L, Goldstein H, Calderon T M, Berman J W. CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J Neurosci 2006; 26: 1098–1106, [INFOTRIEVE], [CROSSREF], [CSA]
  • Flores-Villanueva P O, Ruiz-Morales J A, Song C H, Flores L M, Jo E K, Montano M, Barnes P F, Selman M, Granados J. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J Exp Med 2005; 202: 1649–1658, [INFOTRIEVE], [CROSSREF], [CSA]
  • Fuentes M E, Durham S K, Swerdel M R, Lewin A C, Barton D S, Megill J R, Bravo R, Lira S A. Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J Immunol 1995; 155: 5769–5776, [INFOTRIEVE], [CSA]
  • Ghilardi G, Biondi M L, La Torre A, Battaglioli L, Scorza R. Breast cancer progression and host polymorphisms in the chemokine system: role of the macrophage chemoattractant protein-1 (MCP-1) −2518 G allele. Clin Chem 2005; 51: 452–455, [INFOTRIEVE], [CROSSREF], [CSA]
  • Glass J D, Fedor H, Wesselingh S L, McArthur J C. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 1995; 38: 755–762, [INFOTRIEVE], [CROSSREF], [CSA]
  • Gonzalez E, Rovin B H, Sen L, Cooke G, Dhanda R, Mummidi S, Kulkarni H, Bamshad M J, Telles V, Anderson S A, Walter E A, Stephan K T, Deucher M, Mangano A, Bologna R, Ahuja S S, Dolan M J, Ahuja S K. HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci U S A 2002; 99: 13795–13800, [INFOTRIEVE], [CROSSREF], [CSA]
  • Gonzalez-Escribano M F, Torres B, Aguilar F, Rodriguez R, Garcia A, Valenzuela A, Nunez-Roldan A. MCP-1 promoter polymorphism in Spanish patients with rheumatoid arthritis. Hum Immunol 2003; 64: 741–744, [INFOTRIEVE], [CROSSREF], [CSA]
  • Gonzalez-Scarano F, Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 1999; 22: 219–240, [INFOTRIEVE], [CROSSREF], [CSA]
  • Hong S B, Jin S Y, Park H J, Jung J H, Sim W Y. Analysis of the monocyte chemoattractant protein 1 −2518 promoter polymorphism in Korean patients with alopecia areata. J Korean Med Sci 2006; 21: 90–94, [INFOTRIEVE], [CSA]
  • Hou J, Major E O. Direct and indirect mechanisms of HIV-1 neuropathogenesis in the human central nervous system. Adv Exp Med Biol 2001; 493: 29–34, [INFOTRIEVE], [CSA]
  • Karrer S, Bosserhoff A K, Weiderer P, Distler O, Landthaler M, Szeimies R M, Muller-Ladner U, Scholmerich J, Hellerbrand C. The −2518 promotor polymorphism in the MCP-1 gene is associated with systemic sclerosis. J Invest Dermatol 2005; 124: 92–98, [INFOTRIEVE], [CROSSREF], [CSA]
  • Kaul M, Garden G A, Lipton S A. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001; 410: 988–994, [INFOTRIEVE], [CROSSREF], [CSA]
  • Kelder W, McArthur J C, Nance-Sproson T, McClernon D, Griffin D E. Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol 1998; 44: 831–835, [INFOTRIEVE], [CROSSREF], [CSA]
  • Kim H L, Lee D S, Yang S H, Lim C S, Chung J H, Kim S, Lee J S, Kim Y S. The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE. Am J Kidney Dis 2002; 40: 1146–1152, [INFOTRIEVE], [CROSSREF], [CSA]
  • Letendre S, Marquie-Beck J, Singh K K, de Almeida S, Zimmerman J, Spector S A, Grant I, Ellis R. The monocyte chemotactic protein-1 −2578G allele is associated with elevated MCP-1 concentrations in cerebrospinal fluid. J Neuroimmunol 2004; 157: 193–196, [INFOTRIEVE], [CROSSREF], [CSA]
  • Mankowski J L, Queen S E, Clements J E, Zink M C. Cerebrospinal fluid markers that predict SIV CNS disease. J Neuroimmunol 2004; 157: 66–70, [INFOTRIEVE], [CROSSREF], [CSA]
  • McArthur J C. HIV dementia: an evolving disease. J Neuroimmunol 2004; 157: 3–10, [INFOTRIEVE], [CROSSREF], [CSA]
  • McArthur J C, Brew B J, Nath A. Neurological complications of HIV infection. Lancet Neurol 2005; 4: 543–555, [INFOTRIEVE], [CROSSREF], [CSA]
  • Mengozzi M, De Filippi C, Transidico P, Biswas P, Cota M, Ghezzi S, Vicenzi E, Mantovani A, Sozzani S, Poli G. Human immunodeficiency virus replication induces monocyte chemotactic protein-1 in human macrophages and U937 promonocytic cells. Blood 1999; 93: 1851–1857, [INFOTRIEVE], [CSA]
  • Modi W S, Goedert J J, Strathdee S, Buchbinder S, Detels R, Donfield S, O'Brien S J, Winkler C. MCP-1-MCP-3-Eotaxin gene cluster influences HIV-1 transmission. AIDS 2003; 17: 2357–2365, [INFOTRIEVE], [CROSSREF], [CSA]
  • Mori H, Kaneko Y, Narita I, Goto S, Saito N, Kondo D, Sato F, Ajiro J, Saga D, Ogawa A, Sakatsume M, Ueno M, Tabei K, Gejyo F. Monocyte chemoattractant protein-1 A-2518G gene polymorphism and renal survival of Japanese patients with immunoglobulin A nephropathy. Clin Exp Nephrol 2005; 9: 297–303, [INFOTRIEVE], [CROSSREF], [CSA]
  • Muhlbauer M, Bosserhoff A K, Hartmann A, Thasler W E, Weiss T S, Herfarth H, Lock G, Scholmerich J, Hellerbrand C. A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. Gastroenterology 2003; 125: 1085–1093, [INFOTRIEVE], [CROSSREF], [CSA]
  • Murray E A, Rausch D M, Lendvay J, Sharer L R, Eiden L E. Cognitive and motor impairments associated with SIV infection in rhesus monkeys. Science 1992; 255: 1246–1249, [INFOTRIEVE], [CROSSREF], [CSA]
  • Nei M. Molecular evolutionary genetics. Columbia University Press, New York 1987
  • Neuenburg J K, Brodt H R, Herndier B G, Bickel M, Bacchetti P, Price R W, Grant R M, Schlote W. HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 31: 171–177, [INFOTRIEVE], [CSA]
  • Persidsky Y, Ghorpade A, Rasmussen J, Limoges J, Liu X J, Stins M, Fiala M, Way D, Kim K S, Witte M H, Weinand M, Carhart L, Gendelman H E. Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis. Am J Pathol 1999; 155: 1599–1611, [INFOTRIEVE], [CSA]
  • Pola R, Flex A, Gaetani E, Proia A S, Papaleo P, Giorgio A D, Straface G, Pecorini G, Serricchio M, Pola P. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer's disease in Italians. Exp Gerontol 2004; 39: 1249–1252, [INFOTRIEVE], [CROSSREF], [CSA]
  • Rovin B H, Lu L, Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Comm 1999; 259: 344–348, [INFOTRIEVE], [CROSSREF], [CSA]
  • Sacktor N, McDermott M P, Marder K, Schifitto G, Selnes O A, McArthur J C, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida J A, Cohen B, Epstein L. HIV-associated cognitive impairment before and after the advent of combination therapy. J NeuroVirol 2002; 8: 136–142, [INFOTRIEVE], [CSA]
  • Sekine O, Nishio Y, Egawa K, Nakamura T, Maegawa H, Kashiwagi A. Insulin activates CCAAT/enhancer binding proteins and proinflammatory gene expression through the phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. J Biol Chem 2002; 277: 36631–36639, [INFOTRIEVE], [CROSSREF], [CSA]
  • Sharer L R, Baskin G B, Cho E S, Murphey-Corb M, Blumberg B M, Epstein L G. Comparison of simian immunodeficiency virus and human immunodeficiency virus encephalitides in the immature host. Ann Neurol 1988; 23(Suppl)S108–S112, [INFOTRIEVE], [CROSSREF], [CSA]
  • Sibal L R, Samson K J. Nonhuman primates: a critical role in current disease research. Ilar J 2001; 42: 74–84, [INFOTRIEVE], [CSA]
  • Simeoni E, Hoffmann M M, Winkelmann B R, Ruiz J, Fleury S, Boehm B O, Marz W, Vassalli G. Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and type 2 diabetes mellitus. Diabetologia 2004; 47: 1574–1580, [INFOTRIEVE], [CROSSREF], [CSA]
  • Szalai C, Duba J, Prohaszka Z, Kalina A, Szabo T, Nagy B, Horvath L, Csaszar A. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 −2518 G/G genotype in CAD patients. Atherosclerosis 2001a; 158: 233–239, [INFOTRIEVE], [CROSSREF], [CSA]
  • Szalai C, Kozma G T, Nagy A, Bojszko A, Krikovszky D, Szabo T, Falus A. Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J Allergy Clin Immunol 2001b; 108: 375–381, [INFOTRIEVE], [CROSSREF], [CSA]
  • Tosi A J, Morales J C, Melnick D J. Paternal, maternal, and biparental molecular markers provide unique windows onto the evolutionary history of macaque monkeys. Evol Int J Org Evol 2003; 57: 1419–1435, [CSA]
  • Wagner K, Dendorfer U, Chilla S, Schlondorff D, Luckow B. Identification of new regulatory sequences far upstream of the mouse monocyte chemoattractant protein-1 gene. Genomics 2001; 78: 113–123, [INFOTRIEVE], [CROSSREF], [CSA]
  • Wegscheider B J, Weger M, Renner W, Posch U, Ulrich S, Hermann J, Ardjomand N, Haller-Schober E M, El-Shabrawi Y. Role of the CCL2/MCP-1 −2518A > G gene polymorphism in HLA-B27 associated uveitis. Mol Vis 2005; 11: 896–900, [INFOTRIEVE], [CSA]
  • Weiss J M, Nath A, Major E O, Berman J W. HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. J Immunol 1999; 163: 2953–2959, [INFOTRIEVE], [CSA]
  • Weiss L, Si-Mohamed A, Giral P, Castiel P, Ledur A, Blondin C, Kazatchkine M D, Haeffner-Cavaillon N. Plasma levels of monocyte chemoattractant protein-1 but not those of macrophage inhibitory protein-1alpha and RANTES correlate with virus load in human immunodeficiency virus infection. J Infect Dis 1997; 176: 1621–1624, [INFOTRIEVE], [CSA]
  • Wu D T, Woodman S E, Weiss J M, McManus C M, D'Aversa T G, Hesselgesser J, Major E O, Nath A, Berman J W. Mechanisms of leukocyte trafficking into the CNS. J NeuroVirol 2000; 6(Suppl)S82–S85, 1[INFOTRIEVE], [CSA]
  • Yang B, Houlberg K, Millward A, Demaine A. Polymorphisms of chemokine and chemokine receptor genes in type 1 diabetes mellitus and its complications. Cytokine 2004; 26: 114–121, [INFOTRIEVE], [CROSSREF], [CSA]
  • Zhou Z H, Chaturvedi P, Han Y L, Aras S, Li Y S, Kolattukudy P E, Ping D, Boss J M, Ransohoff R M. IFN-gamma induction of the human monocyte chemoattractant protein (hMCP)-1 gene in astrocytoma cells: functional interaction between an IFN-gamma-activated site and a GC-rich element. J Immunol 1998; 160: 3908–3916, [INFOTRIEVE], [CSA]
  • Zink M C, Clements J E. A novel simian immunodeficiency virus model that provides insight into mechanisms of human immunodeficiency virus central nervous system disease. J NeuroVirol 2002; 8(Suppl)42–48, 2[INFOTRIEVE], [CROSSREF], [CSA]
  • Zink M C, Coleman G D, Mankowski J L, Adams R J, Tarwater P M, Fox K, Clements J E. Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis. J Infect Dis 2001; 184: 1015–1021, [INFOTRIEVE], [CROSSREF], [CSA]
  • Zink M C, Suryanarayana K, Mankowski J L, Shen A, Piatak M, Jr, Spelman J P, Carter D L, Adams R J, Lifson J D, Clements J E. High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis. J Virol 1999a; 73: 10480–10488, [INFOTRIEVE], [CSA]
  • Zink M C, Uhrlaub J, DeWitt J, Voelker T, Bullock B, Mankowski J, Tarwater P, Clements J, Barber S. Neuroprotective and anti-human immunodeficiency virus activity of minocycline. JAMA 2005; 293: 2003–2011, [INFOTRIEVE], [CSA]
  • Zink W E, Zheng J, Persidsky Y, Poluektova L, Gendelman H E. The neuropathogenesis of HIV-1 infection. FEMS Immunol Med Microbiol 1999b; 26: 233–241, [INFOTRIEVE], [CSA]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.